Similar models recapitulate relevant mutations in Isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) mainly found in low-grade gliomas, secondary glioblastomas, and acute myeloid leukemia (AML) [60], without the limitations of the earlier models. This evidence concerns the gene IDH1 and acute myeloid leukemia.